U.S. Markets open in 3 hrs 56 mins

GE Deal to Sell Its Biopharma Unit to Danaher Could Be at Risk, Says Analyst

Al Root

Danaher might be experiencing buyer’s remorse after GE biopharma competitors posted weak results. The purchase agreement might make remorse moot.